Late-Onset Isolated Growth Hormone Deficiency.

growth growth hormone deficiency growth hormone stimulation test idiopathic short stature

Journal

JCEM case reports
ISSN: 2755-1520
Titre abrégé: JCEM Case Rep
Pays: England
ID NLM: 9918609886906676

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 16 11 2022
medline: 1 11 2023
pubmed: 1 11 2023
entrez: 1 11 2023
Statut: epublish

Résumé

Two male patients, who presented at 13.5 and 13.9 years of age with growth failure and short stature, were ultimately diagnosed with isolated growth hormone deficiency (GHD). Patient 1 was first evaluated when his height declined from -0.67 SD to -1.3 SD. He had a peak growth hormone (GH) concentration to GH stimulation test (GHST) of 16.9 ng/mL (16.9 μg/L) and remained untreated. As puberty advanced, his height decreased further to -1.65 SD. A second GHST while his serum testosterone was 79 ng/dL (2.74 nmol/L) had a peak GH of 5.4 ng/mL (5.4 μg/L), consistent with GHD. He was treated with GH for 4.8 years and reached adult height of 180.5 cm (0.57 SD), gaining 2.22 SDS. Patient 2, height -2.63 SD, had an unstimulated peak GH concentration of 19 ng/mL (19 μg/L). As puberty advanced, his height decreased further to -2.96 SD. Repeat peak GH concentration was 9.2 ng/mL (9.2 μg/L) when serum testosterone was 83.9 ng/dL (2.91 nmol/L). GH treatment resulted in rapid increase of height velocity from 1.8 cm/year to 11.3 cm/year in 6 months, consistent with GHD. Both patients demonstrate that GHD may develop over time and cannot be excluded by a single GHST. Longitudinal monitoring of children with poor growth as puberty progresses is essential to uncover GHD.

Identifiants

pubmed: 37908469
doi: 10.1210/jcemcr/luad011
pii: luad011
pmc: PMC10580422
doi:

Types de publication

Case Reports

Langues

eng

Pagination

luad011

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

Références

Front Endocrinol (Lausanne). 2022 Jun 09;13:902364
pubmed: 35757429
Endocr Connect. 2021 Mar;10(3):R125-R138
pubmed: 33543731
Pediatrics. 1983 Jul;72(1):65-70
pubmed: 6408595
Mol Cell Pediatr. 2020 Nov 3;7(1):16
pubmed: 33140249
Pediatr Ann. 2012 Apr;41(4):e1-9
pubmed: 22494211
J Pediatr. 1997 Mar;130(3):481-4
pubmed: 9063430
BMJ. 2011 Mar 11;342:c7157
pubmed: 21398350
Horm Res Paediatr. 2016;86(6):361-397
pubmed: 27884013
Nat Rev Endocrinol. 2021 Oct;17(10):608-624
pubmed: 34417587
J Clin Endocrinol Metab. 2000 Nov;85(11):3990-3
pubmed: 11095419

Auteurs

Julie G Samuels (JG)

Division of Pediatric Endocrinology and Diabetes, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Sri Nikhita Chimatapu (SN)

Division of Pediatric Endocrinology, UCLA Mattel Children's Hospital, Los Angeles, CA 90095, USA.

Martin O Savage (MO)

William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London, London E1 2AD, UK.

Robert Rapaport (R)

Division of Pediatric Endocrinology and Diabetes, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Classifications MeSH